Diversified Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.04M Sell
33,796
-21,838
-39% -$3.06M 0.11% 115
2026
Q2
$7.03M Buy
55,634
+15,148
+37% +$2M 0.11% 100
2026
Q1
$5.64M Sell
40,486
-6,384
-14% -$894K 0.1% 111
2025
Q4
$5.75M Buy
46,870
+3,641
+8% +$442K 0.11% 112
2025
Q3
$4.8M Buy
43,229
+8,422
+24% +$957K 0.1% 117
2025
Q2
$3.86M Sell
34,807
-31
-0.1% -$3.3K 0.09% 131
2025
Q1
$3.9M Buy
34,838
+383
+1% +$39.5K 0.1% 123
2024
Q4
$3.18M Buy
34,455
+1,019
+3% +$91.7K 0.08% 151
2024
Q3
$2.8M Buy
33,436
+449
+1% +$34.3K 0.07% 169
2024
Q2
$2.26M Buy
32,987
+3,483
+12% +$232K 0.06% 182
2024
Q1
$2.16M Sell
29,504
-3,201
-10% -$246K 0.07% 177
2023
Q4
$2.65M Sell
32,705
-4,860
-13% -$378K 0.09% 127
2023
Q3
$2.82M Sell
37,565
-5,393
-13% -$415K 0.11% 109
2023
Q2
$3.31M Sell
42,958
-105
-0.2% -$8.37K 0.12% 100
2023
Q1
$3.57M Buy
43,063
+1,763
+4% +$146K 0.14% 90
2022
Q4
$3.55M Buy
41,300
+5,992
+17% +$475K 0.15% 84
2022
Q3
$2.18M Buy
35,308
+632
+2% +$39.9K 0.1% 106
2022
Q2
$2.14M Sell
34,676
-853
-2% -$52.8K 0.09% 122
2022
Q1
$2.11M Buy
35,529
+1,982
+6% +$127K 0.07% 137
2021
Q4
$2.44M Buy
33,547
+2,723
+9% +$188K 0.08% 127
2021
Q3
$2.15M Sell
30,824
-2,209
-7% -$155K 0.08% 132
2021
Q2
$2.28M Buy
33,033
+1,311
+4% +$87.5K 0.08% 123
2021
Q1
$2.05M Sell
31,722
-1,161
-4% -$74.9K 0.08% 126
2020
Q4
$1.92M Sell
32,883
-628
-2% -$37.9K 0.08% 126
2020
Q3
$2.12M Buy
33,511
+3,684
+12% +$255K 0.1% 113
2020
Q2
$2.3M Buy
29,827
+32
+0.1% +$2.45K 0.12% 93
2020
Q1
$2.23M Buy
29,795
+591
+2% +$40.8K 0.13% 86
2019
Q4
$1.9M Buy
29,204
+7,282
+33% +$474K 0.09% 98
2019
Q3
$1.39M Sell
21,922
-2,115
-9% -$138K 0.07% 101
2019
Q2
$1.62M Sell
24,037
-128
-0.5% -$8.42K 0.08% 93
2019
Q1
$1.57M Buy
24,165
+1,031
+4% +$68.5K 0.08% 92
2018
Q4
$1.45M Buy
+23,134
New +$1.62M 0.08% 89

Other funds holding GILD

Diversified Trust's GILD Position: Q3 2026 in Review

Diversified Trust reduced its Gilead Sciences (GILD) stake by 39% in Q3 2026, selling an estimated $3.06M and leaving 33,796 shares worth $5.04M. The position accounts for 0.11% of the portfolio, ranked #115.

Diversified Trust first reported a position in GILD in Q4 2018 and has held it in 32 quarters since. The position peaked at $7.03M in Q2 2026. 2,308 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Diversified Trust held 33,796 shares of Gilead Sciences worth $5.04M as of Q3 2026.
  • Diversified Trust sold 21,838 Gilead Sciences shares in Q3 2026, an estimated $3.06M.
  • Gilead Sciences made up 0.11% of Diversified Trust's portfolio in Q3 2026, its #115 holding.
  • Diversified Trust first reported a position in Gilead Sciences in Q4 2018 and has held it in 32 quarters since.
  • Diversified Trust's Gilead Sciences position peaked at $7.03M in Q2 2026.
  • 2,308 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Diversified Trust's 13F filing for Q3 2026, filed 6 Nov 2026.